Activating SIRT1: a new strategy to prevent atherosclerosis?

Cardiovasc Res. 2008 Nov 1;80(2):163-4. doi: 10.1093/cvr/cvn245. Epub 2008 Sep 10.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Animals
  • Apolipoproteins E / deficiency
  • Apolipoproteins E / genetics
  • Apoptosis
  • Atherosclerosis / enzymology
  • Atherosclerosis / physiopathology
  • Atherosclerosis / prevention & control*
  • Disease Models, Animal
  • Endothelium, Vascular / enzymology*
  • Endothelium, Vascular / pathology
  • Endothelium, Vascular / physiopathology
  • Humans
  • Lipoproteins, LDL / metabolism
  • Mice
  • Mice, Knockout
  • Mice, Transgenic
  • Nitric Oxide Synthase Type II / metabolism
  • Nitric Oxide Synthase Type III
  • Sirtuin 1
  • Sirtuins / genetics
  • Sirtuins / metabolism*
  • Up-Regulation
  • Vasodilation

Substances

  • Apolipoproteins E
  • Lipoproteins, LDL
  • oxidized low density lipoprotein
  • Nitric Oxide Synthase Type II
  • Nitric Oxide Synthase Type III
  • Nos3 protein, mouse
  • SIRT1 protein, human
  • Sirtuin 1
  • Sirtuins